Undosa Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth %
- Profit Growth -389.08%
- Net Worth -12.54%
- Total Assets -9.73%
About Undosa Healthcare
Undosa Healthcare Private Limited (UHPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 November 2018 (Six years and two months 21 days old ). Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ndubueze Onyechukwugoziri and Saroj Tigga serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U93000TN2018PTC125894
-
Company No.
125894
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Nov 2018
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Undosa Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ndubueze Onyechukwugoziri
|
Director | 03-Oct-2020 | Current |
|
Saroj Tigga
|
Director | 30-Nov-2021 | Current |
Financial Performance of Undosa Healthcare.
Undosa Healthcare Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 389.08% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Undosa Healthcare?
Unlock access to Undosa Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Safrac Pharma Private LimitedNdubueze Onyechukwugoziri is a mutual person
-
Curaxin Healthcare Private Limited
Ndubueze Onyechukwugoziri and Saroj Tigga are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Undosa Healthcare?
Unlock and access historical data on people associated with Undosa Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Undosa Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Undosa Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
